Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older
- Study Title
- Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
- Teva Identifier
- BDP-AR-201
- ClinicalTrials.gov Identifier
- NCT00854360
- Study Status
- Completed
- Trial Condition(s)
- Seasonal Female, Maleergic Rhinitis | Hayfever
- Interventions
- Drug: Beclomethasone dipropionate HFA Nasal Aerosol | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 03/01/2009 - 05/01/2009
- Phase
- Phase 2
